California floats extending health insurance subsidies to all adult immigrants

FHS
May 3, 2024
10:42 am

Marisol Pantoja Toribio found a lump in her breast in early January. Uninsured and living in California without legal status and without her family, the usually happy-go-lucky 43-year-old quickly realized how limited her options were.

CDC studies show effectiveness of flu vaccines across all age groups

The prospect of the worrisome triple threat of COVID, RSV and flu was assuaged last year by the effectiveness of flu vaccines.

February 19, 2024

Lisata receives orphan drug designation for pancreatic therapy

LSTA1 helps activate a new uptake pathway that enables co-administered or tethered anti-cancer drugs to penetrate solid tumours. Credit: Nemes Laszlo / Shutterstock.com. Lisata Therapeutics

October 18, 2023

Zynteglo and Skysona combine for 16 patient starts since approvals last year

Bluebird bio’s gene therapy Zynteglo, which was approved by the FDA to treat patients with transfusion-dependent thalassemia last August, hasn’t had many takers. Bluebird said

August 9, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.